Introduction to the Proceedings of the 8th International Symposium on Biological Reactive Intermediates

Terrence J. Monks; Rafael De La Torre

doi:10.1016/j.cbi.2011.03.003

Introduction to the Proceedings of the 8th International Symposium on Biological Reactive Intermediates

Pharmacology and Toxicology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1-2
Number of pages	2
Journal	Chemico-Biological Interactions
Volume	192
Issue number	1-2
DOIs	https://doi.org/10.1016/j.cbi.2011.03.003
State	Published - Jun 30 2011

ASJC Scopus subject areas

Toxicology

Access to Document

10.1016/j.cbi.2011.03.003

Cite this

@article{85ebb86417614224b5c098758285b733,

title = "Introduction to the Proceedings of the 8th International Symposium on Biological Reactive Intermediates",

author = "Monks, {Terrence J.} and {De La Torre}, Rafael",

note = "Funding Information: The International BRI Symposia were initiated 30 years ago and are staged every 5 years through the work of a group of volunteers with interest in the field. Previous meetings were hosted in Turku, Finland (1975), Guildford, England (1980), College Park, Maryland (1985), Tucson, Arizona (1990), Munich, Germany (1995), Paris, France (2000), and Tucson, Arizona (2006). The current Barcelona meeting was co-sponsored by the Southwest Environmental Health Sciences Center and the IMIM-Hospital del Mar. The organizers are grateful for the additional financial support provided by AstraZeneca (Stockholm), Eli Lilly and Co., the U.S. Society of Toxicology, TECNIO (Catalan Gouvernement), AdvanCell, Soft, Agilent Technologies, and Ventana Medical Systems Inc. The success of BRI is very much dependent upon this generous support. An extensive International Advisory Committee was polled for recommendations on the program, which was finally put together by a Steering Committee composed of Dr. M.W. (Drag) Anders (Univ. Rochester), Dr. Tom Baillie (University of Washington), Dr. Judy Bolton (University of Illinois-Chicago), Dr. Serrine Lau (University of Arizona), Dr. Peter Moldeus (Astra Zeneca, Sweden), Dr. Terrence Monks (University of Arizona), Dr. Bob Snyder (Rutgers Univ.), Dr. David Williams (Oregon State University), and Dr. Donna Zhang (University of Arizona). Rafael de la Torre (IMIM-Hospital del Mar, Barcelona) was chairperson of the Local Organizing Committee for the Barcelona meeting, and was assisted by A. Messeguer (CSIC, Barcelona), G. Jane (Palaupharma, Spain), J.A. Vericat (Zeltia Group, Spain), E. Vilanova (University of Alicante), M.J. Gomez-Lechon (University of Valencia, Hospital La Fe), J. Segura (IMIM-Hospital del Mar, Barcelona), and M. Carbo (IMIM-Hospital del Mar, Barcelona). Copyright: Copyright 2011 Elsevier B.V., All rights reserved.",

year = "2011",

month = jun,

day = "30",

doi = "10.1016/j.cbi.2011.03.003",

language = "English (US)",

volume = "192",

pages = "1--2",

journal = "Chemico-Biological Interactions",

issn = "0009-2797",

publisher = "Elsevier Ireland Ltd",

number = "1-2",

}

TY - JOUR

T1 - Introduction to the Proceedings of the 8th International Symposium on Biological Reactive Intermediates

AU - Monks, Terrence J.

AU - De La Torre, Rafael

N1 - Funding Information: The International BRI Symposia were initiated 30 years ago and are staged every 5 years through the work of a group of volunteers with interest in the field. Previous meetings were hosted in Turku, Finland (1975), Guildford, England (1980), College Park, Maryland (1985), Tucson, Arizona (1990), Munich, Germany (1995), Paris, France (2000), and Tucson, Arizona (2006). The current Barcelona meeting was co-sponsored by the Southwest Environmental Health Sciences Center and the IMIM-Hospital del Mar. The organizers are grateful for the additional financial support provided by AstraZeneca (Stockholm), Eli Lilly and Co., the U.S. Society of Toxicology, TECNIO (Catalan Gouvernement), AdvanCell, Soft, Agilent Technologies, and Ventana Medical Systems Inc. The success of BRI is very much dependent upon this generous support. An extensive International Advisory Committee was polled for recommendations on the program, which was finally put together by a Steering Committee composed of Dr. M.W. (Drag) Anders (Univ. Rochester), Dr. Tom Baillie (University of Washington), Dr. Judy Bolton (University of Illinois-Chicago), Dr. Serrine Lau (University of Arizona), Dr. Peter Moldeus (Astra Zeneca, Sweden), Dr. Terrence Monks (University of Arizona), Dr. Bob Snyder (Rutgers Univ.), Dr. David Williams (Oregon State University), and Dr. Donna Zhang (University of Arizona). Rafael de la Torre (IMIM-Hospital del Mar, Barcelona) was chairperson of the Local Organizing Committee for the Barcelona meeting, and was assisted by A. Messeguer (CSIC, Barcelona), G. Jane (Palaupharma, Spain), J.A. Vericat (Zeltia Group, Spain), E. Vilanova (University of Alicante), M.J. Gomez-Lechon (University of Valencia, Hospital La Fe), J. Segura (IMIM-Hospital del Mar, Barcelona), and M. Carbo (IMIM-Hospital del Mar, Barcelona). Copyright: Copyright 2011 Elsevier B.V., All rights reserved.

PY - 2011/6/30

Y1 - 2011/6/30

UR - http://www.scopus.com/inward/record.url?scp=79958077231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958077231&partnerID=8YFLogxK

U2 - 10.1016/j.cbi.2011.03.003

DO - 10.1016/j.cbi.2011.03.003

M3 - Editorial

C2 - 21402060

AN - SCOPUS:79958077231

VL - 192

SP - 1

EP - 2

JO - Chemico-Biological Interactions

JF - Chemico-Biological Interactions

SN - 0009-2797

IS - 1-2

ER -

Introduction to the Proceedings of the 8th International Symposium on Biological Reactive Intermediates

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this